Finally, in these newly diagnosed PAD patients, no significant correlations were found between the expression of Fc receptors (CD16 and CD64 on PMN and CD16 on monocytes) and their IgG levels after replacement treatment (p > 0.05, in all cases). Here, FCGR3A is linked to peripheral arterial disease.